Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001435452 | SCV001638275 | likely benign | Cranioectodermal dysplasia 1 | 2021-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002542259 | SCV003609397 | uncertain significance | Inborn genetic diseases | 2022-02-10 | criteria provided, single submitter | clinical testing | The c.1292A>G (p.E431G) alteration is located in exon 12 (coding exon 12) of the IFT122 gene. This alteration results from a A to G substitution at nucleotide position 1292, causing the glutamic acid (E) at amino acid position 431 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |